Wellness in PSP and CBD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSilke Cresswell
About this trial
The goal of this interventional study is to evaluate the feasiblity and effectiveness of a multimodal lifestyle program for individuals living with Progressive Supranuclear Palsy or Corticobasal Deneration. The main objectivess of the study are to:
1. Assess the feasibility of the program 2. Assess the effects of the program on emotional wellbeing and quality of life 3. Assess the effects of the program on caregiver burden
Participants will join an 8-week program combining chair yoga, vocal strengthening, and peer support groups, conducted virtually. Participants will complete pre- and post- intervention questionnaires related to emotional wellbeing and quality of life. When applicable, care partners will be asked to complete a caregiver burden questionnaire.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age over 18 years.
PSP or CBD diagnosis based on Movement Disorder Society criteria.
Disqualifiers
Significant cognitive impairment.
Inability to fill in electronic questionnaires or understand study instructions.
Any contraindication for exercise based on the Physical Activity Readiness for Everyone Questionnaire (PAR-Q+).
Trial design
Design model
Single group
Treatments tested in this trial
Exercise and Peer Support
BehavioralChair yoga, and SongShine vocal strengthening, and. peer support groups,
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: InterventionExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Attendance and retention rates
Time frame
From enrollment to completion of post- intervention questionnairesSponsors and contacts
Click on the lead sponsor to view all of their trials.
Silke Cresswell
Lead sponsor
University of British Columbia
Sponsor institution
University of California, San Diego
Collaborator
CurePSP
Collaborator
Parkinson Canada
Collaborator
Pacific Parkinson's Research Centre
Collaborator
Source ClinicalTrials.gov